Chemical Structure (Duloxetine 01)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 72162-1600
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 72162-1600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine 02)
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Figure 6 (Duloxetine 07)
Figure 8 (Duloxetine 08)
Percentage of patents improved is not available as the provided text is not readable.*
Figure 9 (Duloxetine 09)
Figure 10 (Duloxetine 10)
Label (Lbl721621600)
This text appears to be a description of a medication called Duloxetine. Each capsule contains 44.9 mg of Duloxetine Hydrochloride, which is equivalent to 40 mg of Duloxetine. The medication is in the form of delayed-release capsules and should be stored at a temperature between 25°C (77°F) and 30°C (86°F). It should be kept out of reach of children and dispensed in a tightly closed container. The medication guide should be given to each patient. The manufacturer of the medication is Tow Pharmaceutical Europe, S.L., located in Burbank, CA, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
